Ambac Financial Group 2026 Q3 Earnings Call
Review the key takeaways and the transcript of this earnings call.
- Insurance Distribution revenue grew 35% to $58 million in the 3rd quarter of 2026, including organic growth of 23% and revenue from the October 2025 acquisition of ArmadaCare.
- Year-to-date Insurance Distribution adjusted EBITDA to shareholders reached $43.4 million, and its margin expanded almost 9 percentage points to 22.2%; 3rd quarter adjusted EBITDA to shareholders rose nearly 40% to $8.3 million, with a 14.2% margin.
- Octave reported a net loss to shareholders of $13.8 million, or $0.31 per share, compared with a net loss from continuing operations to shareholders of $31.7 million, or $0.65 per share, in the 3rd quarter of 2025.
- Consolidated adjusted EBITDA to shareholders was $3.3 million, compared with negative $2.9 million a year ago, while consolidated adjusted net loss to shareholders narrowed to $1.3 million, or $0.03 per share, from $10 million, or $0.21 per share.
- Everspan’s 3rd quarter gross premiums written were $99 million, up 2%; net premiums written and earned were each $26 million, up 44% and 52%, respectively.
- Everspan’s combined ratio improved to 100.6% from 112.9% in the 3rd quarter of 2025, and its loss ratio was 57.1% compared with 84.5%; adjusted EBITDA was $2.2 million.
- Corporate expenses were $10 million in the 3rd quarter, down from $27 million a year ago, while adjusted corporate expenses fell to $7.3 million from $9.5 million.
STOCKNOW INSIGHTS
Continue with outlook and guidance.
Log in to unlock executive comments and Q&A highlights.
Log in for the full summaryStockNow uses AI to translate and summarize earnings calls. Accuracy and completeness are not guaranteed.
Transcript
Preview the first fifteen paragraphs, organized by speaker.
Ladies and gentlemen, good morning and welcome to the Octave Specialty Group's third quarter 2026 earnings call. The simulcast systems are in listen-only mode. A brief question and answer session will follow the formal presentation. If anyone should require operator assistance during the conference, please signal the operator by pressing star and zero on your telephone keypad. As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Phil Stefano, Head of Investor Relations. Please go ahead. Thank you.
Good morning, and welcome to Octave's third quarter 2026 call to discuss financial results. Speaking today will be Claude LeBlanc, President and Chief Executive Officer, and David Trick, Chief Financial Officer. They will discuss the financial results of our business and the current market environment. After the prepared remarks, we will take your questions. Also available for Q&A today will be executives from our Insurance Distribution segment. For those of you following along on the webcast, during the prepared remarks, we will be highlighting several slides from the earnings presentation, which can be located on our website. Our call today includes forward-looking statements. The company cautions investors that any forward-looking statements involves risks and uncertainties and is not a guarantee of future performance. Actual results may differ materially from those expressed or implied in the forward-looking statements due to a variety of factors.
These factors are described under the forward-looking statements in our earnings press release and in our most recent 10-K and 10-Q filed with the SEC. We do not undertake any obligation to update forward-looking statements. Also, in our prepared remarks or responses to questions, we may mention some non-GAAP financial measures. Reconciliation to those non-GAAP measures is included in our earnings press release, operating supplement, and other materials available in the investor relations section of our website, octavegroup.com. Now I would like to turn the call over to Claude.
Thank you, Phil, and good morning, everyone. Octave delivered a solid quarter, driven by strong organic growth in our Insurance Distribution business, product expansion, the addition of a bolt-on team, and continued expansion of our distribution and capacity relationships. Our core Insurance Distribution segment grew total revenue 35% in the third quarter to $58 million, driven by organic growth of 23% and the October 2025 acquisition of ArmadaCare. This organic growth, which we believe is well ahead of sector peers, was consistent with our seasonally adjusted third quarter plan. On a year-to-date basis, Insurance Distribution's adjusted EBITDA to shareholders has nearly tripled to $43.4 million, and margins have expanded almost 9 percentage points to 22.2%. These results reflect the strength of our purposely diversified portfolio and the embedded value of our scaling MGAs. Our Specialty P&C segment continued to benefit from the repositioning of its program business.
Everspan delivered adjusted EBITDA to shareholders of $2.2 million compared to less than $0.1 million in the prior year period, and net income of $1.3 million. Net premiums written and earned grew 44% and 52%, respectively. Everspan now supports 30 programs, up from 25 a year ago. David will provide more details on the financial results for the quarter in his commentary. Overall, I am very pleased that our strategy of building a leading diversified MGA platform, combining top underwriting teams with an AI-enhanced integrated technology and data architecture, continues to gain momentum and strengthen our underlying fundamentals as our platform scales. Before commenting further on our segments, I want to start with a market backdrop to provide some context for how we are managing the business today and how we are positioning Octave for 2027. Through 2026, abundant capacity has made the P&C market more competitive.
Global commercial rates declined for the ninth consecutive quarter, driven by, one, the depth of capacity from strong earnings, two, new entrants, including foreign carriers and ILS capital, and three, the significant movement of capital into the E&S market. Broadly, the rate dynamics we discussed last quarter persist, and the U.S. and global P&C insurance markets continue to soften. Property has continued to absorb most of the pressure as rates fell roughly 10% again in the third quarter, following low to mid-teens declines at mid-year, led by the wholesale and large property segments. Turning to the London markets, for the large casualty market, competition remains robust, but rates have held up better than in large property. Our alternative classes, meanwhile, are exhibiting a low correlation to the broader P&C markets, with rates holding firm. Energy remains one area we continue to view with caution.
Years of compounding rate reductions have coincided with elevated loss experience. That combination is not sustainable, and we are encouraged that the market is beginning to recognize it, and we are managing our exposures here accordingly. Casualty SME classes, including general liability and select specialty classes, continue to achieve rate increases ranging from mid-single to double digits. We see them as attractive opportunities for growth. As we consider the broader market trends, it is important to remember that current rate decreases follow several years of meaningful rate increases, so most classes are softening from a position of strength. Rate adequacy across most of our classes remains strong, and the portfolios we manage remain attractive for our capacity partners.
Furthermore, our diversification across property, casualty, specialty, and A&H means no single pricing cycle defines our results, and A&H follows a different cycle entirely, which I'll come back to shortly. As we continue to scale our business, we remain focused on specialist niches where expertise matters most and where pricing remains adequate, and in many cases, strengthening. Turning to our insurance distribution segment. We believe our continued strong organic growth at over 35% year to date reflects the diversification and the success of our rapidly scaling MGA portfolio. Our expanding portfolio, led by the class of 2024 and 2025 MGAs, are more than offsetting the market headwinds. In addition to driving growth in established lines, future organic growth will be supported by, one, bolt-on team launches as an alternative to startup MGAs, and two, the launching of adjacent products in our existing platforms.
For example, in recent weeks, we announced three new programs. Year to date, we have launched seven product adjacencies in the U.S., leveraging existing infrastructure, distribution relationships, and underwriting talent. Another key area of growth is our A&H business, which makes up about a third of our portfolio and provides a buffer against current market headwinds. Our A&H businesses are growing through new revenue opportunities, supported by expanded distribution relationships, while at the same time maintaining strong retention and favorable pricing. Across our A&H businesses, we are seeing an increase in premiums together with solid organic growth, including for our most recent acquisition, ArmadaCare. Pricing in A&H continues to be a tailwind, with double-digit rate increases due to surging healthcare costs. A&H provides us a growing earnings base that is largely uncorrelated with P&C pricing and adds further diversification to our results, and we expect this trend will continue.
We are also seeing encouraging early momentum heading into the January 1 renewals, the most important renewal season for A&H. We continue to see a strong pipeline of startup MGA opportunities, particularly in the U.S., but also in Europe. Our aligned capacity partnership model, broad distribution, and a technology-enabled operating platform positions us well to attract top talent. At the same time, we remain highly selective, partnering only with proven teams with strong track records that we believe can build durable businesses over the long term. As we look forward, our 2027 capacity is largely lined up, and we expect to be oversubscribed, driven in large part by our track record of profitable and less volatile underwriting results. Turning to our specialty P&C segment. Everspan's results this quarter reflect our continued focus on disciplined underwriting, program oversight, and proactive portfolio management.
We've also begun to diversify Everspan's routine risk portfolio, selectively expanding into package and non-cat property business to complement our existing casualty book and create a more balanced underwriting portfolio over time. We believe the diversification of the book, combined with the continued scaling of the business, will position us well for profitable growth at an attractive combined ratio. Since the quarter end, we announced that Everspan entered into an agreement to sell its wholly owned subsidiary, Providence Washington Insurance Company. This transaction is expected to close by early next year and will simplify Everspan's operating structure, making it more efficient while further strengthening its rating agency capital and tangible book value. The announcement does not change Everspan's strategy, underwriting capabilities, or commitment to its trading partners. During the quarter, Everspan continued to support our insurance distribution business through the writing of two programs.
Finally, an update on our operations, technology, and AI. Starting with operations. As you may remember, during the fourth quarter last year, we implemented a new target operating model at corporate that materially reduced our run rate costs for 2026. We are actively exploring initiatives for further savings in 2027 as we continue the global integration of our business and plan to implement the initial phase of a target operating model for our international operations later in the year. During the third quarter, the market experienced another round of concern around AI disintermediating insurance distribution. Our view has not changed. The majority of lines we underwrite are complex specialty risks, and in that environment, we believe AI makes MGAs more productive, not less relevant. Over time, we believe it can be a competitive differentiator across specialty insurance.
We continue to execute on the data, AI, and technology initiatives we laid out earlier in the year, and all of our MGAs are now on their target technology platforms, with the rollout of our AI-driven intake across our U.S. MGAs largely complete. We are already seeing significant benefits in the form of accelerated submission vetting, leading to increased underwriting velocity, which will further improve our operating leverage in the future. The same diversification that carries us through the cycle also shapes how we build technology. Our enterprise underwriting platform is designed to use AI to create proprietary bespoke tools around each MGA's niche and expertise, all on one platform and one set of data, giving us consistent oversight while maintaining what makes each MGA uniquely competitive.
This model will help our teams to choose the right risks, grow where the returns are strong, and step back where pricing no longer makes sense, reinforcing the discipline that supports stable capacity and durable fee income. I will now turn the call over to David to review our third quarter results in more detail.
David? Thank you, Claude, and good morning, everyone.
FULL TRANSCRIPT
Continue the full translated transcript in StockNow.
Log in to unlock every statement, the English original, and speaker-by-speaker history.
Log in for the full transcriptCall participants
7 people spoke on this call — only 2 are shown here.
PARTICIPANT LIST
View participant details in StockNow.
Log in to see executives and analysts, their roles, and complete speaking history.
Log in to view all participantsKeep exploring
